Novartis Rises On Solid Q2 Earnings

The drug maker's earnings per share beat expectations and revenues were roughly in line.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.